How should I evaluate pruritic urticarial papules and plaques of pregnancy (PUPPP) in a third‑trimester pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Evaluation of PUPPP in Third-Trimester Pregnancy

PUPPP is a clinical diagnosis based on characteristic pruritic urticarial papules and plaques starting on abdominal striae in the third trimester, and the primary goal of evaluation is to exclude intrahepatic cholestasis of pregnancy (ICP), which carries significant fetal risk, unlike PUPPP which is benign.

Key Diagnostic Features of PUPPP

The diagnosis relies on recognizing the classic presentation 1:

  • Distribution: Lesions begin on the abdomen within striae gravidarum, then spread to proximal thighs and extremities
  • Morphology: Pruritic urticarial papules and plaques (may occasionally have small vesicles 2-4mm, but never true bullae) 2
  • Periumbilical sparing: Characteristic feature that helps distinguish from other conditions 3
  • Timing: Typically third trimester (89% of cases), predominantly in primigravidas (72%) 4
  • Associated factors: Multiple gestation (50% of cases), excessive maternal weight gain 4, 3

Critical Differential: Exclude ICP First

The most important step is measuring serum bile acids and liver transaminases to rule out ICP 1. This distinction is critical because:

  • ICP carries significant fetal risk (stillbirth, preterm delivery, meconium-stained fluid) while PUPPP is completely benign to the fetus 1
  • ICP presents with pruritus WITHOUT a primary rash (though excoriations may develop), predominantly affecting palms and soles, worse at night 1
  • PUPPP presents WITH a visible rash of papules and plaques 1

Laboratory Evaluation

Order these tests to exclude ICP and other causes 1:

  • Serum total bile acids (diagnostic threshold >10 μmol/L for ICP) 5
  • Liver transaminases (AST/ALT)
  • Total bilirubin
  • Consider: TSH, renal function if clinical suspicion for other causes of pruritus 1

Other Differential Diagnoses to Consider

Based on clinical presentation, distinguish PUPPP from 1:

  • Atopic eruption of pregnancy (AEP): Eczematous rash on face, neck, antecubital/popliteal fossae—different distribution pattern
  • Pemphigoid gestationis (PG): Rare, develops vesicles and BULLAE (not just small vesicles), requires skin biopsy with direct immunofluorescence to confirm
  • ICP: Pruritus without primary rash, palms/soles predominance, elevated bile acids

When to Perform Skin Biopsy

Biopsy is NOT routinely needed for typical PUPPP 6, 7. However, consider biopsy with direct immunofluorescence if:

  • Presence of true bullae (suggests pemphigoid gestationis, which has fetal implications) 2
  • Atypical distribution or morphology
  • Diagnostic uncertainty between PUPPP and pemphigoid gestationis 2

Expected findings in PUPPP 7, 8:

  • Nonspecific mild lymphohistiocytic perivascular infiltrate with variable eosinophils
  • Negative direct immunofluorescence (key to exclude pemphigoid gestationis)

Clinical Pitfalls

  • Don't assume all pregnancy pruritus is benign: Always measure bile acids to exclude ICP, which requires specific management and early delivery 1
  • Small vesicles can occur in PUPPP but true bullae indicate pemphigoid gestationis 2
  • Postpartum onset is rare but possible: PUPPP occasionally presents in the immediate postpartum period 9, 3
  • Face, palms, and soles are usually spared in PUPPP, though exceptions exist 2, 8

Prognosis and Counseling

Once PUPPP is confirmed and ICP excluded:

  • Reassure about benign nature: No maternal or fetal risks 6, 4, 7
  • Self-limited course: Resolves spontaneously at or shortly after delivery (average 3 weeks) 4
  • Rarely recurs in subsequent pregnancies 6, 7
  • Treatment is symptomatic: topical corticosteroids and oral antihistamines are generally adequate 4, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.